Pharma Research Library | Pharma Info Index Research | Innovation | Opportunities |

Srikanth ReddyThummalapelly1, Mounika Arrabelli2, Raghuram Reddy Adidala*1 1Sri Shivani College of Pharmacy, Mulugu road, Warangal, A.P, India. 2Synapse Life Sciences, Nakkalagutta, Hanamkonda, Warangal, A.P, India. Abstract In cancer, the taxane of choice has historically been paclitaxel however, there is no substantial evidence that docetaxel  may be the preferred taxane in this disease. Docetaxel has many preclinical advantages over paclitaxel and ... Read More »